WallStSmart

Thomson Reuters Corporation Common Shares (TRI)vsXerox Corp (XRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Thomson Reuters Corporation Common Shares generates 1% more annual revenue ($7.83B vs $7.76B). TRI leads profitability with a 21.2% profit margin vs -11.9%. XRX appears more attractively valued with a PEG of 0.15. TRI earns a higher WallStSmart Score of 63/100 (C+).

TRI

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 7.5Value: 4.0Quality: 6.5
Piotroski: 5/9Altman Z: 2.63

XRX

Buy

60

out of 100

Grade: C

Growth: 6.0Profit: 3.5Value: 8.3Quality: 3.5
Piotroski: 2/9Altman Z: 1.07
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TRISignificantly Overvalued (-47.1%)

Margin of Safety

-47.1%

Fair Value

$60.64

Current Price

$97.35

$36.71 premium

UndervaluedFair: $60.64Overvalued
XRXUndervalued (+65.3%)

Margin of Safety

+65.3%

Fair Value

$5.96

Current Price

$3.43

$2.53 discount

UndervaluedFair: $5.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TRI4 strengths · Avg: 8.5/10
Profit MarginProfitability
21.2%9/10

Keeps 21 of every $100 in revenue as profit

Debt/EquityHealth
0.299/10

Conservative balance sheet, low leverage

Operating MarginProfitability
28.3%8/10

Strong operational efficiency at 28.3%

EPS GrowthGrowth
47.2%8/10

Earnings expanding 47.2% YoY

XRX3 strengths · Avg: 9.3/10
PEG RatioValuation
0.1510/10

Growing faster than its price suggests

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
22.0%8/10

Revenue surging 22.0% year-over-year

Areas to Watch

TRI2 concerns · Avg: 4.0/10
PEG RatioValuation
1.594/10

Expensive relative to growth rate

P/E RatioValuation
27.9x4/10

Moderate valuation

XRX4 concerns · Avg: 2.5/10
Market CapQuality
$435.96M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-170.0%2/10

ROE of -170.0% — below average capital efficiency

Altman Z-ScoreHealth
1.072/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : TRI

The strongest argument for TRI centers on Profit Margin, Debt/Equity, Operating Margin. Profitability is solid with margins at 21.2% and operating margin at 28.3%.

Bull Case : XRX

The strongest argument for XRX centers on PEG Ratio, Price/Book, Revenue Growth. Revenue growth of 22.0% demonstrates continued momentum. PEG of 0.15 suggests the stock is reasonably priced for its growth.

Bear Case : TRI

The primary concerns for TRI are PEG Ratio, P/E Ratio.

Bear Case : XRX

The primary concerns for XRX are Market Cap, Piotroski F-Score, Return on Equity. Debt-to-equity of 7.76 is elevated, increasing financial risk.

Key Dynamics to Monitor

TRI profiles as a mature stock while XRX is a growth play — different risk/reward profiles.

XRX carries more volatility with a beta of 2.46 — expect wider price swings.

XRX is growing revenue faster at 22.0% — sustainability is the question.

TRI generates stronger free cash flow (722M), providing more financial flexibility.

Bottom Line

TRI scores higher overall (63/100 vs 60/100), backed by strong 21.2% margins. XRX offers better value entry with a 65.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Thomson Reuters Corporation Common Shares

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Thomson Reuters Corporation provides business information services in the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Xerox Corp

INDUSTRIALS · BUSINESS EQUIPMENT & SUPPLIES · USA

Xerox Holdings Corporation, a workplace technology company, designs, develops and sells document management systems and solutions in the United States, Europe, Canada and internationally. The company is headquartered in Norwalk, Connecticut.

Visit Website →

Want to dig deeper into these stocks?